Hsbc Holdings PLC increased its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 7.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 638,529 shares of the exchange traded fund’s stock after purchasing an additional 46,339 shares during the quarter. Hsbc Holdings PLC owned approximately 0.96% of SPDR S&P Biotech ETF worth $78,049,000 at the end of the most recent reporting period.
A number of other large investors have also recently added to or reduced their stakes in XBI. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth $27,000. Intesa Sanpaolo Wealth Management bought a new position in SPDR S&P Biotech ETF in the 4th quarter worth $30,000. SHP Wealth Management acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth $31,000. Legacy Wealth Managment LLC ID bought a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $32,000. Finally, Smartleaf Asset Management LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $32,000.
SPDR S&P Biotech ETF Stock Performance
Shares of NYSEARCA:XBI opened at $145.86 on Tuesday. The stock’s 50-day moving average is $133.84 and its 200-day moving average is $127.95. The company has a market cap of $9.31 billion, a P/E ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 52-week low of $80.90 and a 52-week high of $146.77.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
